Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Trial of Induction Chemotherapy (ICT) Followed by Concurrent Chemoraditherapy (CR) With Monoclonal Antibody Cetuximab in Locally Advanced Head and Neck Squamous Cell Cancer

This study has been terminated.
(Principle Investigator left the institution.)
Information provided by (Responsible Party):
Syed Jafri, Louisiana State University Health Sciences Center Shreveport Identifier:
First received: March 24, 2011
Last updated: March 4, 2014
Last verified: March 2014
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: June 2014
  Primary Completion Date: February 2014 (Final data collection date for primary outcome measure)